Following are peer-reviewed journal articles for which I provided professional medical writing support.

In addition to manuscripts, I have written many, many posters and abstracts. I am always grateful for the opportunity to follow a data set from abstract to poster to manuscript, which works well for everyone involved.

Bilder DA, Arnold GL, Dimmock D, et al. Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria. Am J Med Genet A. 2022;188:768-778.

Statland JM, Campbell C, Desai U, et al. Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2022 Apr 15. Epub ahead of print.

Roth T, Rosenberg R, Morin CM, et al. Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder. Sleep Med. 2022;90:249-257.

Chen G, Pedarla V, Null KD, Cazzetta SE, Khan QR, Schwartz DA. Health care costs and resource utilization among patients with Crohn's disease with and without perianal fistula. Inflamm Bowel Dis. 2021 Sep 15:izab198.

Alexis AF, Desai SR, Han G, Jacobson A. Fixed-combination halobetasol propionate and tazarotene lotion for psoriasis in patients with skin of color. J Drugs Dermatol. 2021;20:744.

Sanon Aigbogun M, Oberdhan D, Doane MJ, et al. Disconnect in assessments of autosomal dominant polycystic kidney disease burden between patients and physicians: a survey study. Int J Nephrol Renovasc Dis. 2021;14:105-115.

Waltrip RW 2nd, Mahler N, Ahsan A, Herbert LB. Effect of health care providers' focused discussion and proactive education about relapse management on patient reporting of multiple sclerosis relapse. Int J MS Care. 2021;23:151-156.

Agbo F, Isaacson SH, Gil R, et al. Pharmacokinetics and comparative bioavailability of apomorphine sublingual film and subcutaneous apomorphine formulations in patients with Parkinson's disease and "OFF" episodes: results of a randomized, three-way crossover, open-label study. Neurol Ther. 2021;10:693-709.

Tanghetti EA, Bhatia N, Drew S, Jacobson A. Fixed-combination halobetasol propionate/tazarotene lotion for psoriasis in patients with 3%-5% affected body surface area. J Drugs Dermatol. 2021;20:829-836.

Cheng JY, Moline M, Zammit GK, Filippov G, Bsharat M, Hall N. Respiratory safety of lemborexant in healthy subjects: a single-dose, randomized, double-blind, placebo-controlled, crossover study. Clin Drug Investig. 2021 Mar 16. Epub ahead of print.

Dayal S, Aluri J, Hall N, Filippov G, Moline M, Reyderman L, Landry I. Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant. Pharmacol Res Perspect. 2021;9:e00758.

Agbo F, Crass RL, Chiu YY, Chapel S, Galluppi G, Blum D, Navia B. Population pharmacokinetic analysis of apomorphine sublingual film and subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease. Clin Transl Sci2021;14:1464-1475.

Vermeire S, Chiorean M, Panés J, et al. Long-term safety and efficacy of etrasimod for ulcerative colitis: results from the open-label extension of the OASIS study. J Crohns Colitis. 2021:jjab016.

Moline M, Zammit G, Yardley J, Pinner K, Kumar D, Perdomo C, Cheng JY. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials. Postgrad Med. 2021;133:71-81.

Wong W, Wu N, Gupta R, Mansfield AS. Utilization trends and factors associated with ROS1 testing among patients with advanced non-small-cell lung cancer in US community practices. Clin Lung Cancer. 2020:S1525-7304(20)30213-8.

Gottlieb A, Lebwohl M, Liu C, Israel RJ, Jacobson A. Malignancy rates in brodalumab clinical studies for psoriasis. Am J Clin Dermatol. 2020;21:421-430.

Tauber J. A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction. Cornea. 2020;39:403-407.

Cheng JY, Filippov G, Moline M, Zammit GK, Bsharat M, Hall N. Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study. J Sleep Res. 2020:e13021.

Pepose JS, Qazi MA, Devries DK. Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity. Clin Ophthalmol. 2019;13:571-579.

Borin MT, Lo A, Barnes CN, Pendyala S, Bourdet DL. Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function. Int J Chron Obstruct Pulmon Dis. 2019;14:2305-2318.

Roca-Ferrer J, Pujols L, Pérez-González M, Alobid I, Callejas B, Vicens-Artés S, Fuentes M, Valero A, Picado C, Castor D, Nguyen D, Mullol J. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers. Allergy Asthma Clin Immunol. 2018;14:86.

Gadde KM, Vetter ML, Iqbal N, Hardy E, Öhman P; DURATION-NEO-2 study investigators. Efficacy and safety of auto injected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study. Diabetes Obes Metab. 2017;19:979-988.

Baxter R, Eaton A, Hansen J, Aukes L, Caspard H, Ambrose CS. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49 years. Vaccine. 2017;35:1254-1258.

Lundkvist P, Pereira MJ, Katsogiannos P, Sjöström CD, Johnsson E, Eriksson JW. Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Diabetes Obes Metab. 2017;19:1276-1288.

McLean HQ, Caspard H, Griffin MR, Poehling KA, Gaglani M, Belongia EA, Talbot HK, Peters TR, Murthy K, Ambrose CS. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season. Vaccine. 2017;35:2685-2693.

Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP; OPUS-2 Investigators. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study. Ophthalmology. 2015;122:2423-2431.

Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA; IMPACT-HAP Study Group. Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study. Crit Care. 2014;18:R118.

Quartin AA, Scerpella EG, Puttagunta S, Kett DH. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis. 2013;13:561.

Dahlin LB, Bainbridge C, Szczypa PP, Cappelleri JC, Guérin D, Gerber RA. Current trends in the surgical management of Dupuytren’s disease in Europe: the surgeon’s perspective. Eur Orthop Traumatol. 2012;3:25-30.

Butterfield JM, Lawrence KR, Reisman A, Huang DB, Thompson CA, Lodise TP. Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data. J Antimicrob Chemother. 2012;67:494-502.

Bainbridge C, Dahlin LB, Szczypa PP, Cappelleri JC, Guérin D, Gerber RA. Current trends in the surgical management of Dupuytren’s disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012;3:31-41.

Polished, High-Level Medical Publications
... On Deadline!


© Lisa Baker PhD LLC. All rights reserved.
Designed by Metcalfe Media.
Photography by Studio Macleod.